DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions delive...
Top Biotech Gainers: ZCMD Surges 190%, LABT Advances On Nu-3 Progress, ARWR Hits The Targets
Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
DarioHealth plans to use USD 23.5 million offering proceeds for working capital, investments and acquisitions
The AI Infrastructure Spillover and the Resilience of the Real Economy
M&A, AI Drug Discovery, and Late-Stage Clinical Readouts Define US Biotech Q2 Trajectory
Bankruptcies, Splits, and Real AI Revenue: Surviving the Market's Fringes